| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9308361 | Kidney International | 2005 | 9 Pages |
Abstract
Ultrahigh dosing of irbesartan (900 mg once daily) is generally safe and offers additional renoprotection independent of changes in systemic blood pressure and GFR in comparison to the currently recommended dose of 300 mg.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Kasper Rossing, Katrine J. Schjoedt, Berit R. Jensen, Frans Boomsma, Hans-Henrik Parving,